IBT
XLRN
International Biotechnology Trust’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-60,500
| Closed | -$7.59M | – | 76 |
|
|
2021
Q2 | $7.59M | Hold |
60,500
| – | – | 2% | 16 |
|
|
2021
Q1 | $8.2M | Sell |
60,500
-10,500
| -15% | -$1.42M | 2.17% | 17 |
|
|
2020
Q4 | $9.06M | Hold |
71,000
| – | – | 2.48% | 16 |
|
|
2020
Q3 | $7.98M | Buy |
71,000
+53,000
| +294% | +$5.96M | 2.58% | 16 |
|
|
2020
Q2 | $1.73M | Hold |
18,000
| – | – | 0.57% | 29 |
|
|
2020
Q1 | $1.62M | Sell |
18,000
-39,000
| -68% | -$3.5M | 0.74% | 25 |
|
|
2019
Q4 | $3.02M | Buy |
57,000
+27,000
| +90% | +$1.43M | 1.09% | 25 |
|
|
2019
Q3 | $1.18M | Hold |
30,000
| – | – | 0.55% | 36 |
|
|
2019
Q2 | $1.23M | Hold |
30,000
| – | – | 0.46% | 47 |
|
|
2019
Q1 | $1.4M | Buy |
+30,000
| New | +$1.4M | 0.52% | 49 |
|
|
2017
Q4 | – | Sell |
-153,633
| Closed | -$5.75M | – | 71 |
|
|
2017
Q3 | $5.75M | Sell |
153,633
-24,010
| -14% | -$898K | 2.24% | 14 |
|
|
2017
Q2 | $5.4M | Buy |
177,643
+7,037
| +4% | +$214K | 2.05% | 13 |
|
|
2017
Q1 | $4.51M | Buy |
170,606
+152,000
| +817% | +$4.02M | 1.73% | 17 |
|
|
2016
Q4 | $475K | Buy |
+18,606
| New | +$475K | 0.21% | 46 |
|